Our Pricing

Wegovy Pen Doses Available - In Stock UK Supply

Published on: June 03, 2026

Searching for wegovy pen doses available UK with reliable stock? At Cured Pharmacy, we maintain consistent supply of Wegovy semaglutide pens with transparent upfront pricing and same-day prescription approval from UK-registered clinicians. Each Wegovy pen delivers four weekly doses, supporting your structured weight loss programme without supply interruptions.

How Many Doses Are in a Wegovy Pen?

Each Wegovy FlexTouch pen contains exactly four doses, designed for once-weekly subcutaneous injection over a four-week period [1]. This multi-dose format differs from some competitor products that use single-dose pens, offering better value and fewer packaging requirements.

The pen mechanism locks after the fourth injection, preventing accidental overdose. Patients progress through a structured dose escalation schedule: starting at 0.25mg weekly for month one, then 0.5mg, 1.0mg, 1.7mg, before reaching the maintenance dose of 2.4mg weekly [1]. Each strength requires a separate pen, meaning you'll use one 0.25mg pen for your first month, one 0.5mg pen for your second month, and so forth.

This graduated dosing protocol, validated in the STEP clinical trial programme, significantly reduces gastrointestinal side effects compared to starting at higher doses immediately [2]. Our superintendent pharmacist Tarun Kumar advises patients to mark their injection days on a calendar to maintain consistent weekly timing, which optimises semaglutide's appetite-suppressing effects.

Wegovy Stock Availability at UK Pharmacies

Following MHRA supply restrictions in 2023, many UK pharmacies experienced intermittent Wegovy shortages. At Cured Pharmacy, we maintain direct relationships with licensed UK wholesalers and update our online inventory in real-time, ensuring you see only genuinely available stock when you complete your clinical assessment.

We prioritise existing patients during allocation periods, guaranteeing continuity for those mid-treatment. New patients can check current availability on our product page before starting their free consultation — we never collect payment for out-of-stock items, unlike some online services that place customers on indefinite waiting lists.

Our GPhC-registered pharmacy (9012511) sources exclusively from MHRA-approved UK suppliers. Every Wegovy pen dispensed carries full UK product licensing and patient information leaflets in English, with batch numbers traceable through the Yellow Card reporting scheme should you experience any adverse effects requiring documentation.

What to Do If Your Dose Is Temporarily Unavailable

If a specific Wegovy strength is temporarily out of stock, our clinical team can assess whether maintaining your current dose for an additional month is appropriate, or whether switching to an alternative GLP-1 treatment like Mounjaro or Saxenda better serves your weight loss goals. Never attempt to adjust your Wegovy dose independently — all changes require prescriber approval to maintain safety and efficacy.

Wegovy Dosing Schedule Explained

The Wegovy dose escalation follows a five-month titration schedule mandated by the product licence. Month one uses 0.25mg weekly, month two 0.5mg weekly, month three 1.0mg weekly, month four 1.7mg weekly, and month five onwards 2.4mg weekly as the maintenance dose [1].

This gradual increase allows your digestive system to adapt to semaglutide's effects on gastric emptying and gut motility. In the STEP-1 trial, participants following this exact protocol achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2]. Rushing the escalation or skipping doses compromises both tolerability and clinical outcomes.

Some patients experience nausea or reduced appetite during the first few weeks. These effects typically diminish as your body adjusts, but if symptoms persist beyond week three of any new dose, contact your prescriber before your next injection. Our clinical team can authorise an additional month at your current strength if escalation proves too rapid for your individual tolerance.

Missing a Wegovy Dose: Clinical Guidance

If you miss a scheduled Wegovy injection and fewer than five days have passed, administer the missed dose immediately and resume your normal weekly schedule. If more than five days have elapsed, skip the missed dose entirely and inject your next scheduled dose on the original day [1]. Never double-dose to compensate — this increases side effect risk without improving efficacy.

How Wegovy Compares to Other Weight Loss Injections

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. This differs from Mounjaro's tirzepatide, which activates both GLP-1 and GIP receptors simultaneously. In head-to-head comparisons, tirzepatide demonstrated superior weight reduction — the SURPASS-2 trial showed 15mg tirzepatide produced 12.4kg average weight loss versus 6.2kg with 1mg semaglutide over 40 weeks [3].

However, Wegovy's longer market presence means more extensive real-world safety data, particularly regarding cardiovascular outcomes. The SELECT trial demonstrated that semaglutide 2.4mg weekly reduced major adverse cardiovascular events by 20% in patients with pre-existing cardiovascular disease, a benefit not yet established for tirzepatide [4].

Saxenda uses liraglutide, an older GLP-1 agonist requiring daily injections rather than weekly. While effective, the daily administration and typically lower weight loss percentages make Saxenda more suitable for patients who prefer gradual results or cannot tolerate the higher-potency weekly injections.

Wegovy Pricing and UK Prescription Requirements

At Cured Pharmacy, Wegovy starts from £79.00 per pen, with final cost determined by your prescribed dose strength. We display exact pricing before you begin the clinical consultation, eliminating surprise charges at checkout. This transparent approach reflects our commitment to accessible weight management treatments across the UK.

All Wegovy purchases require a valid UK prescription issued after clinical assessment by one of our GMC-registered prescribers. The free online consultation takes under three minutes and evaluates your BMI, medical history, current medications, and weight loss goals. Approval typically occurs within two hours during pharmacy operating hours, with prescriptions sent directly to our dispensary for same-day processing.

We accept payment via major credit cards, debit cards, and digital wallets. Discreet packaging carries no external pharmacy branding, and all deliveries require age verification upon receipt. Patients on maintenance doses can set up recurring monthly deliveries through their online account, ensuring continuous treatment without manual reordering.

Does Insurance Cover Wegovy in the UK?

Most private health insurance policies in the UK do not cover weight loss medications, including Wegovy, as they are typically classified as lifestyle treatments rather than essential medicines. However, some employers offer enhanced health plans that include obesity medication coverage — check your policy documents or contact your insurer directly. NHS prescription of Wegovy remains limited to specialist weight management services in most regions, subject to strict BMI and comorbidity criteria set by local integrated care boards.

Starting Wegovy: What to Expect in Your First Month

The initial 0.25mg dose serves primarily as a tolerability test rather than a therapeutic dose. Most patients notice mild appetite reduction and earlier satiety during meals, but significant weight loss typically begins during the 1.0mg phase in month three [2]. This delayed onset surprises some patients expecting immediate results — setting realistic expectations improves long-term adherence.

Common first-month side effects include nausea, constipation, and occasional headaches. These symptoms affect approximately 44% of patients during the STEP trials but diminish substantially by week four [2]. Eating smaller, more frequent meals and avoiding high-fat foods reduces gastrointestinal discomfort. Stay well-hydrated and contact your prescriber if you experience persistent vomiting or signs of dehydration.

Inject Wegovy subcutaneously into your abdomen, thigh, or upper arm, rotating injection sites weekly to prevent lipodystrophy. The pen needle is 4mm long — significantly shorter than needles used for intramuscular injections — and most patients report minimal discomfort. Store unused pens in the refrigerator at 2-8°C, but allow the pen to reach room temperature for 30 minutes before injecting to reduce injection site reactions.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and is subject to prescriber approval based on individual medical suitability.